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Background: The white blood cell and neutrophil count has been considered as risk factors for coronary artery disease(CAD), while the data of 
monocytes’ role in CAD is rare. Monocyte can be classified by CD14 and CD16 surface molecule and each monocyte subset has different functional 
characteristics in atherosclerosis. Therefore, we hypothesized that monocyte subset might be associated with CAD.
methods: We enrolled 208 consecutive patients(mean age; 63±11 years) with stable(SAP) or unstable(UAP) angina and control patients whose 
coronary angiogram showed no significant stenosis. We measured each monocyte subset using flow cytometry.
results: 1. The percent of CD14++CD16+ monocyte was lower in unstable angina compared to control(4.8±5.1 vs 9.1±6.4 %, p<0.01) or 
stable angina patients(4.8±5.1 vs 7.5±7.4 %, p<0.01). 2. The percent of CD14++CD16- monocyte was higher in unstable angina compared to 
control(72.4±13.8 vs 53.4±12.2%, p<0.01) or stable angina patients(72.4±13.8 vs 61.0±13.4 %, p<0.01) (Figure 1). 3. Among the stable angina 
patients, the percent of CD14++CD16- monocyte was lower in statin treated patients than non-statin treated patients(58.8±14.8 vs 64.0±11.4 %, 
p<0.01).
conclusions: The elevated CD14++CD16- monocyte subset might be a risk factor coronary artery disease and also be involved in plaque 
vulnerability. 
